ROSIER scale and FAST test in acute stroke (also searched with alternate eponym spelling Recognition of Stroke in the Emergency Room scale and Face Arm Speech Time test, ICD-10: I63.9) represent foundational clinical screening instruments deployed across emergency medical services and acute hospital environments to optimize the triage, recognition, and rapid therapeutic intervention for patients experiencing an acute cerebrovascular event ¹. Acute stroke remains a leading global cause of permanent adult disability and mortality, where hyperacute time-to-treatment metrics directly dictate functional neurological recovery. The FAST test (Face, Arm, Speech, Time) is an intuitive, highly sensitive mnemonic tool engineered primarily for pre-hospital personnel and the lay public to identify cardinal signs of stroke rapidly ¹. Meanwhile, the ROSIER scale (Recognition of Stroke in the Emergency Room) provides a more rigorous, weighted bedside scoring matrix designed for clinicians to differentiate true acute cerebrovascular insults from common neurological and systemic stroke mimics—such as hypoglycemic episodes, complex migraine auras, post-ictal states (Todd's paresis), and functional or toxic-metabolic encephalopathies ¹. Integrating both instruments into clinical pathways ensures that time-sensitive reperfusion therapies, including intravenous thrombolysis and endovascular thrombectomy, are administered within narrow therapeutic windows.

Etiology & Risk Factors

• Cerebrovascular Pathologies: Ischemic stroke secondary to large artery atherosclerosis, cardioembolism (e.g., non-valvular atrial fibrillation, mechanical heart valves, infective endocarditis), small vessel lacunar disease, and cryptogenic etiologies or dissection of the cervicocephalic arteries ¹.
• Hemorrhagic Mechanisms: Intracerebral hemorrhage (ICH) driven by chronic hypertension, cerebral amyloid angiopathy, ruptured saccular aneurysms, arteriovenous malformations (AVMs), and coagulopathies or therapeutic anticoagulation overdose ¹.
• Modifiable Cardiovascular Risk Factors: Essential systemic arterial hypertension (the single most potent risk factor), dyslipidemia, type 2 diabetes mellitus, cigarette smoking, obstructive sleep apnea, heavy alcohol consumption, and physical inactivity ¹.
• Non-Modifiable Risk Factors: Advanced chronological age, biological sex (higher incidence in males at younger ages, but higher lifetime mortality and morbidity in females), positive family history of cerebrovascular disease, and prior history of transient ischemic attack (TIA) or stroke ¹.
• Stroke Mimic Etiologies: Metabolic derangements (severe hypoglycemia, hyperosmolar hyperglycemic state), primary or metastatic intracranial neoplasms, acute intracranial infections (meningitis, encephalitis), labyrinthine vertigo, and peripheral mononeuropathies (e.g., Bell's palsy mimicking isolated facial droop) ¹.

Pathophysiology

The pathophysiological cascade underlying acute focal neurological deficits initiates with the abrupt cessation or critical reduction of regional cerebral blood flow (CBF) below the critical metabolic threshold required to maintain neuronal viability (normal CBF is approximately 50 mL/100g/min; ischemia occurs when CBF drops below 18 mL/100g/min, and cell death ensues rapidly below 10 mL/100g/min) ¹. In ischemic stroke, this reduction stems from an occlusive thrombus or embolus lodged within a major intracranial conduit artery, such as the middle cerebral artery (MCA), internal carotid artery (ICA), or basilar artery ¹. The immediate consequence is localized tissue ATP depletion, which paralyzes ATP-dependent active transport mechanisms, notably the sarcolemmal Na⁺/K⁺-ATPase pump ¹.

Failure of ionic pumps precipitates a massive net influx of sodium, chloride, and water into the intracellular compartment, causing cytotoxic edema, while extracellular accumulation of potassium triggers membrane depolarization and the pathological, uncontrolled release of excitatory amino acids, principally glutamate ¹. Excessive synaptic glutamate overstimulates post-synaptic N-methyl-D-aspartate (NMDA) and AMPA receptors, provoking an unmitigated influx of intracellular calcium ions (Ca²⁺) ¹. This calcium overload activates destructive enzymatic cascades, including phospholipases, proteases, endonucleases, and nitric oxide synthases, which systematically dismantle cellular membranes, cytoskeletal architecture, and nuclear DNA, culminating in necrotic and apoptotic neuronal death ¹.

Surrounding the irreversibly damaged core ischemic zone lies the ischemic penumbra—a functionally impaired but structurally viable rim of tissue receiving collateral blood supply ¹. The primary objective of emergency clinical screening via tools like the FAST test and ROSIER scale, coupled with rapid neuroimaging, is the identification of patients with a salvageable penumbra who can benefit from emergent recanalization therapies before core infarct expansion is complete ¹.

Clinical Presentation & Classic Clinical Signs

• History & Cardinal Symptoms: Patients typically present with sudden, focal neurological deficits manifesting as acute unilateral motor weakness (hemiparesis or hemiplegia), sensory loss (hemianesthesia), visual disturbances (homonymous hemianopia or amaurosis fugax), gait ataxia, dizziness, or profound acute vertigo. Higher cortical dysfunction features include expressive or receptive aphasia, dysarthria, neglect syndromes, and acute confusion ¹.
• Physical Examination & Named Clinical Signs:
  • Central Facial Palsy: Weakness of the lower half of the face with preservation of forehead wrinkling, distinguishing central nervous system lesions from peripheral cranial nerve VII palsies (Bell's palsy).
  • Pronator Drift: Inability to maintain both arms extended with palms supine with eyes closed; downward drift and inward pronation of the affected upper limb indicates corticospinal tract dysfunction.
  • Gaze Deviation: Forced conjugate deviation of the eyes ("eyes look toward the lesion" in hemispheric stroke, or "away from the hemiparesis" in brainstem lesions).
  • Aphasia and Neglect Signs: Receptive fluent aphasia (Wernicke's), non-fluent expressive aphasia (Broca's), or unilateral spatial neglect demonstrated by failure to respond to stimuli presented in the contralateral hemispace.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Staging, Classification & Clinical Scoring Systems

Differential Diagnosis

Management & Treatment Protocol

• Initial Stabilization & Resuscitation: Execute ABCDE protocol. Secure patent airway, provide supplemental oxygen only if oxygen saturation drops below 94%, establish large-bore intravenous access, and immediately check point-of-care blood glucose. Manage permissive hypertension according to acute guidelines (maintain blood pressure <185/110 mmHg prior to thrombolysis administration) ¹.
• First-Line Medical / Pharmacological Therapy (with exact adult dosing):
  • Intravenous Thrombolysis (IVT): Administer intravenous alteplase at a total dose of 0.9 mg/kg (maximum allowable dose is 90 mg), where 10% of the total calculated dose is given as an initial bolus over 1 minute, followed by the remaining 90% infused continuously over 60 minutes. Administration must occur strictly within 4.5 hours of symptom```html

    ROSIER scale and FAST test in acute stroke (also searched with possessive/alternate eponym spelling where applicable, ICD-10: I63.9) is an essential clinical framework comprising rapid bedside screening instruments designed to optimize the triage, identification, and time-critical management of patients presenting with acute cerebrovascular events ¹. The FAST (Face, Arm, Speech, Time) test serves as a widely recognized public and pre-hospital mnemonic for identifying cardinal stroke symptoms, whereas the Recognition of Stroke in the Emergency Room (ROSIER) scale provides a validated, weighted scoring system used by clinicians to accurately distinguish acute stroke from common stroke mimics such as hypoglycemia, Todd's paresis, migraine, or functional neurological disorders ¹. Rapid deployment of these tools directly impacts door-to-needle times for reperfusion therapies, reducing permanent neurological disability and mortality.

    Etiology & Risk Factors

    • Cerebrovascular Pathologies: Acute ischemic stroke (thromboembolic or large artery atherosclerosis accounting for ~85% of cases) and primary intracerebral hemorrhage (~15% of cases) ¹.
    • Modifiable Vascular Risk Factors: Essential hypertension (the single most potent risk factor), diabetes mellitus, dyslipidemia, atrial fibrillation (conferring high risk of cardioembolic stroke), cigarette smoking, obstructive sleep apnea, and carotid artery stenosis ¹.
    • Non-Modifiable Risk Factors: Advanced age, male biological sex, positive family history of cerebrovascular disease, and prior history of transient ischemic attack (TIA) or stroke ¹.
    • Common Stroke Mimics (Targeted by ROSIER): Hypoglycemia, generalized or focal seizures with post-ictal Todd's paresis, complicated migraine, intracranial mass lesions, systemic infection with encephalopathy, and functional or psychogenic neurological deficits ¹.

    Pathophysiology

    Acute stroke arises from the abrupt cessation of regional cerebral blood flow caused by an occluding thrombus, embolus, or vascular rupture ¹. Deprived of oxygen and glucose, the affected brain tissue undergoes rapid cellular ATP depletion, causing the failure of ATP-dependent sodium-potassium pumps (Na^+/K^+-ATPase) ¹. This ionic failure results in cytotoxic edema, excessive extracellular glutamate accumulation, and massive intracellular calcium influx, triggering an excitotoxic cascade that damages cellular membranes, activates degradative enzymes, and initiates apoptosis ¹. Surrounding the irreversibly damaged core is the ischemic penumbra—hypoperfused, electrically silent tissue whose viability depends on prompt vascular recanalization ¹. Clinical deficits manifest rapidly due to anatomical disruption of specific neural tracts, which are captured at the bedside via structured motor and language assessments like FAST and ROSIER ¹.

    Clinical Presentation & Classic Clinical Signs

    • History & Cardinal Symptoms: Sudden onset of focal neurological deficits, including unilateral facial asymmetry, sudden weakness or numbness involving the arm and/or leg, slurred speech or word-finding difficulties (aphasia), sudden visual field cuts or monocular vision loss, and acute imbalance or vertigo ¹.
    • Physical Examination & Named Clinical Signs:
      • FAST Parameters: Facial droop (uneven smile), arm drift (downward drift of one arm when elevated with eyes closed), and abnormal speech (slurred, inappropriate words, or mute) ¹.
      • ROSIER Specific Signs: Asymmetric facial weakness, asymmetric arm weakness, asymmetric leg weakness, speech disturbance, and visual field defect, contrasted with the absence of seizure activity or loss of consciousness ¹.

    Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

    Diagnostic Modality / Test	Expected Clinical & Radiological / Laboratory Finding
    Gold-Standard Investigation	Urgent non-contrast computed tomography (NCCT) of the head to immediately rule out intracranial hemorrhage and identify early signs of ischemia (e.g., hyperdense middle cerebral artery sign, loss of insular ribbon, effacement of cortical sulci); advanced imaging includes CT angiography (CTA) and CT perfusion (CTP) or MRI diffusion-weighted imaging (DWI).
    Laboratory Panel	Point-of-care capillary blood glucose (mandatory initial test to rule out hypoglycemia mimic), complete blood count (platelet count for thrombolysis safety), coagulation profile (INR, aPTT), baseline renal function (serum creatinine and eGFR prior to iodinated contrast administration), and cardiac biomarkers (troponin).
    Imaging / Radiology (X-ray, US, CT, MRI)	Carotid duplex ultrasonography and transcranial Doppler to evaluate extracranial and intracranial atherosclerosis; echocardiography (transthoracic and transesophageal) to identify cardioembolic sources.
    ECG / Histopathology / Procedural	12-lead ECG and continuous telemetry monitoring to detect occult atrial fibrillation or acute myocardial infarction; neurovascular angiography during mechanical thrombectomy.

    Staging, Classification & Clinical Scoring Systems

    Criterion / Stage / Score Component	Clinical Threshold, Points & Management Implication
    FAST Test Components	Face (droop), Arm (drift), Speech (slurred), Time (call emergency services immediately); binary checklist used for rapid pre-hospital screening.
    ROSIER Scale Scoring	Score ranges from -2 to +5. Points awarded (+1 each) for asymmetric facial weakness, asymmetric arm weakness, asymmetric leg weakness, speech disturbance, and visual field defect. Points subtracted (-1 each) for loss of consciousness and seizure activity. A score > 0 indicates a high probability of acute stroke, prompting urgent stroke team activation.
    NIH Stroke Scale (NIHSS)	11-item neurological examination scale (score 0–42) quantifying stroke severity: minor (1–4), moderate (5–15), moderate-to-severe (16–20), severe (21–42); guides acute treatment eligibility.

    Differential Diagnosis

    Differential Condition	Distinguishing Clinical, Biochemical & Imaging Features
    Hypoglycemia	Rapidly reversible focal neurological deficits upon intravenous dextrose administration; confirmed by low capillary blood glucose (< 60 mg/dL or < 3.3 mmol/L).
    Todd's Paresis	Transient post-ictal focal weakness following a focal or generalized seizure; history of seizure activity or witnessed convulsion, with prompt resolution over hours.
    Complicated Migraine	Accompanied by positive visual phenomena (scintillating scotomas) or gradual march of sensory symptoms, typically preceding headache in younger patients without acute ischemic lesions on MRI.
    Intracranial Mass / Tumor	Subacute or progressive onset of neurological deficits, often accompanied by headache, papilledema, or seizure activity; neuroimaging reveals space-occupying lesion with mass effect.

    Management & Treatment Protocol

    • Initial Stabilization & Resuscitation: Assess and maintain airway, breathing, and circulation (ABCs); administer supplemental oxygen only if oxygen saturation drops below 94%; correct severe hypertension cautiously according to acute stroke guidelines; strictly manage hyperglycemia and fever.
    • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
      • Intravenous Thrombolysis: Recombinant tissue plasminogen activator (alteplase) administered at 0.9 mg/kg (maximum dose 90 mg; 10% given as an initial IV bolus over 1 minute, followed by the remaining 90% infused continuously over 60 minutes) within 4.5 hours of symptom onset, provided no contraindications exist. Alternatively, tenecteplase at 0.25 mg/kg (single IV bolus, max 25 mg) is increasingly utilized.
      • Antiplatelet Therapy: Aspirin 162 mg to 325 mg orally administered within 24 to 48 hours of onset for acute ischemic stroke, deferred for 24 hours if IV alteplase was administered.
    • Surgical / Interventional Indications: Endovascular thrombectomy (EVT) via catheter-based mechanical retrieval for eligible patients with acute ischemic stroke due to large vessel occlusion in the anterior circulation within 6 to 24 hours of last known normal, subject to advanced imaging selection criteria. Decompressive craniectomy is indicated for malignant middle cerebral artery (MCA) infarctions with severe cerebral edema.

    Complications & Prognosis

    • Acute Complications: Hemorrhagic transformation of ischemic stroke (symptomatic intracranial hemorrhage), malignant cerebral edema with increased intracranial pressure and herniation, aspiration pneumonia, deep vein thrombosis (DVT), pulmonary embolism, and post-stroke seizures ¹.
    • Chronic Complications: Permanent motor disability, spasticity, aphasia, post-stroke depression, cognitive impairment, and vascular dementia ¹.
    • Prognosis: Strongly dependent on patient age, baseline stroke severity (NIHSS score), timely administration of reperfusion therapy, extent of the ischemic core on neuroimaging, and prompt rehabilitation ¹.